Funding opportunity

Funding opportunity: Experimental medicine to define mechanisms of gambling disorder: stage one

Start application

Apply for funding for academically led experimental medicine studies in humans that deepen understanding of the causal biological and psychosocial mechanisms underlying the effects of gambling activities, products and interventions on gambling disorder.

Your project must:

  • focus on a mechanistic hypothesis
  • include an experimental intervention or challenge in humans
  • be independent from gambling industry associations

You must be based at a UK research organisation eligible for Medical Research Council (MRC) funding.

The full economic cost (FEC) of your project can be up to £3 million. MRC will fund 80% of the FEC.

Who can apply

This funding opportunity is open to organisations with standard eligibility. Check if your organisation is eligible.

Who is eligible to apply

To be eligible to apply for this funding opportunity you must:

  • show that you will direct the project and be actively engaged in the work
  • be looking to investigate the causes, progression and treatment of human disease

If you do not have a contract of employment for the duration of the proposed project, by submitting an application the research organisation is confirming that, if it is successful:

  • contracts will be extended beyond the end date of the project
  • all necessary support for you and the project will be provided, including mentorship and career development for early career researchers

New investigator applicants

We welcome applications from early career researchers. The new investigator award supports individuals who have demonstrated the potential to become independent researchers, and who are now ready to take the next step towards establishing their own research direction.

If you are applying for this funding opportunity as a ‘new investigator’, you must also:

  • have your research organisation support
  • be able to demonstrate that your skills and experience at the time of your application match those of the ‘transition to independence’ career stage, as set out in the MRC skills and experience table
  • use this grant to support your long-term career goals and chosen career route
  • be able to demonstrate you are the sole intellectual leader of the application and the proposed work

If you meet the eligibility criteria, you can also apply as a new investigator, if you:

  • are employed as a postdoctoral research assistant, although this grant cannot start until your current work finishes
  • hold a lecturer appointment, a junior fellowship or another research staff position
  • hold, or have held, an early career training fellowship such as an MRC skills development fellowship
  • do not have a contract with your chosen host organisation
  • are not currently based at the eligible research organisation that has agreed to host your new investigator award
  • are either a non-clinical or clinically active researcher
  • have any number of years of experience

Who is not eligible to apply as a new investigator

You are not eligible to apply as a new investigator if you have already achieved independence. New investigator awards support individuals who have not previously led a research team or been awarded a substantial grant as fellow or project lead (formally known as principal investigator).

A substantial grant is typically defined as for three or more years and includes salary support for one or more additional team members.

You are also not eligible to apply as a new investigator if you have:

If you are unsure whether you meet the eligibility criteria as a new investigator or have any questions about your eligibility, you should contact gamblingexpmed@mrc.ukri.org to find out whether you can apply.

See further details on the New Investigator Award.

Your other team members (new investigators)

We recognise and support the value of team science and interdisciplinary research, which may be important to your career development. Therefore, project co-leads, specialists and other team roles may be included within your new investigator application.

Your team members should bring essential complementary research, technical expertise or skills to the project, that you as the new investigator project lead cannot provide, or you are aiming to develop.

We encourage you to use the appropriate application sections, such as ‘Applicant and team capability to deliver’, to make your leadership role clear and justify the team around you.

It is not usually appropriate for a current or recent supervisor, or lab head of the new investigator, to be part of the applicant team as this may make your leadership unclear. If this is essential to the proposed work, it must be specifically justified.

Who is not eligible to apply

You are not eligible to apply for this funding opportunity as a project lead if you are based at an international research organisation. This does not include MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine (LSHTM) or MRC/UVRI (Uganda Virus Research Institute) and LSHTM Uganda Research Unit.

If you are employed by these organisations you cannot apply as project lead or project co-lead, but can participate as project partners on an application led by an eligible UK organisation:

  • businesses
  • charity and third sector organisations

However, charities and third sector organisations that are approved UKRI Independent Research Organisations are eligible to apply as project lead or project co-lead.

Further eligibility requirements

Applications must be team based and must bring together diverse people, expertise, experiences, places, and wider stakeholders. This includes people with lived and learned experience from gambling and gambling related harms.

By lived experience, we mean people with direct experience of gambling related harms.

Partnerships with non-academic higher education institutions and people across the third sector, community groups, industry, the public sector, people with lived experience and the public are important. These kinds of collaborations can strengthen the diversity, innovation and potential for impact from research activities.

By ‘industry’ we mean any enterprise that places goods or services on a market and whose commercial activities constitute more than 20% of its annual operations. This definition applies across all sectors and is not limited to organisations within the gambling industry. However, there are sensitivities with respect to partnerships with businesses, the gambling industry or otherwise, meaning additional care should be taken to manage risks and potential conflicts of interest.

Any engagement with industry partners, especially those from the gambling sector, must be demonstrably independent, evidence-based and research-led. Engagement must align with the programme’s public interest objectives to further understanding of gambling-related harms and should be discussed with UKRI prior to submission of an application via the UKRI Research Programme on Gambling inbox at rpginfo@ahrc.ukri.org

All applications will be subject to robust scrutiny through our expert review and governance processes. Particular attention will be paid to the independence and integrity of the research, the source and independence of the findings, and the potential for real-world impact in understanding gambling behaviour and reducing gambling harms.

UKRI wishes to clarify that, as well as not being permitted to host awards, under the Research Programme on Gambling, UKRI does not permit funding to be provided to Gambling Commission licence holders who are subject to the levy.

Co-funding from Gambling Commission license holder is not permitted. Furthermore, UKRI would not expect individual researchers to concurrently hold funding from licence holders subject to the levy while receiving funding from the Research Programme on Gambling.

UKRI does not permit engagement with industries whose core business can be associated with harm to public health or societal wellbeing, in line with our ethical standards and harms-based exclusion principles. This includes the gambling industry.

Exceptions may be made for time-limited, purpose-specific interactions deemed essential to achieving legitimate and high-quality research objectives (for example, access to proprietary datasets or materials), provided that:

  • there is no direct funding or co-authorship from the excluded entity
  • the interaction is subject to robust ethical review and declared transparently
  • appropriate safeguards are in place to prevent undue influence, reputational risk, or conflicts of interest
  • the public benefit of the research demonstrably outweighs the risks of engagement

Such exceptions must be approved in advance through UKRI’s due diligence and governance mechanisms. Please contact rpginfo@ahrc.ukri.org before applying to this opportunity. You should consider UKRI’s policies and guidance on Preventing harm in research when preparing applications to this funding opportunity.

You should declare in the declaration of interest section of your application that you are compliant with these requirements for the duration of the programme.

International researchers

As MRC is the lead funder for this funding opportunity, international researchers can apply as ‘project co-lead (international)’.

Project co-leads (international) make a major intellectual contribution to the design or conduct of the project. Their contribution and added value to the research collaboration should be clearly explained and justified in the application, using the appropriate application sections, such as ‘Applicant and team capability to deliver’.

Read the UKRI project co-lead (international) eligibility for more details. Please contact us if you are uncertain about eligibility.

You should include all other international collaborators (or UK partners not based at approved organisations) as project partners.

Resubmissions

We will not accept uninvited resubmission of applications that were submitted after 1 April 2026 to MRC or the rest of UK Research and Innovation (UKRI). An uninvited resubmission is an application that was previously unsuccessful and has been submitted again without being invited by MRC. This includes applications that are unchanged, minimally revised, or substantially the same as the original submission. Uninvited resubmissions will be rejected.

You should contact us if you are unsure whether your application is a resubmission. Find contacts in the ‘Contact details’ section.

Find out more about UKRI’s resubmission policy.

Equality, diversity and inclusion

We are committed to achieving equality of opportunity for all funding applicants. We encourage applications from a diverse range of researchers.

We support people to work in a way that suits their personal circumstances. This includes:

  • career breaks
  • support for people with caring responsibilities
  • flexible working
  • alternative working patterns

UKRI can offer disability and accessibility support for UKRI applicants and grant holders during the application and assessment process.

What we're looking for

Demand management

Demand management is not being applied to this funding opportunity.

Aim

The overarching aim is to generate a more integrated mechanistic understanding of gambling disorder development, progression, persistence, relapse and recovery which may help identify modifiable targets and build an evidence base for future prevention and treatment strategies. Secondary outcomes could also inform policy changes for example regulation of gambling products and related advertising.

Scope

It is increasingly recognised that gambling disorder arises through complex interactions between gambling products and environments and biological, psychological and social processes. The mechanisms through which these factors interact to shape risk, trajectory and recovery of gambling disorder are poorly understood. Additionally, modern gambling products and environments are rapidly evolving, incorporating features designed to maximise engagement by leveraging human reward, learning and attentional processes.

Advancing our understanding of the causal mechanisms through which gambling disorder develops, progresses and persists and how interventions modulate outcomes is essential. The insights gained will help identify the factors that increase the risk of developing gambling disorder, its progression and persistence, and will inform the development of new prevention and treatment strategies.

Funding is available for academically led experimental medicine studies in humans that generate causal mechanistic insights into the interaction of gambling products and environments with biological and psychosocial processes and how these shape risk, emergence, progression, persistence, relapse, recovery and treatment response of gambling disorder.

Studies must address a clearly articulated gap in the understanding of gambling disorder and include clear, measurable clinical, behavioural, cognitive or neurobiological outcomes. Applications should focus on testing causal biological, cognitive or psychosocial mechanisms underlying gambling disorder emergence, progression, persistence, treatment response, relapse or recovery, including mental health impacts. Applications should move beyond solely identifying correlates and behavioural endpoints to test causal pathways.

For the purposes of this funding opportunity, the term gambling disorder encompasses the clinical condition as defined by recognised diagnostic criteria. The funding opportunity also welcomes research on gambling-related harms, problems, and addictive gambling behaviours that occur below the diagnostic threshold for gambling disorder, provided that the proposed research has clear relevance to understanding gambling disorder and its prevention, identification, or treatment.

Interdisciplinary approaches are encouraged but highly focused projects would equally be in scope. Although not primarily aimed at discovering new treatments, the approach must have a clearly articulated path to impact in identification, treatment, prevention or policy relevant to gambling disorder.

Successful projects will generate new mechanistic insights, including those that may:

  • explore intersections between gambling, gambling products and addiction across biopsychosocial causal domains
  • identify opportunities to modify the development, progression, persistence or recovery of gambling disorder
  • enable the future development of novel therapeutic, diagnostic or intervention approaches
  • also have broader applicability across other mental health and addiction conditions

This funding opportunity will support research that investigates:

  • mechanisms of gambling disorder, including how gambling products, features and environments interact with biological, cognitive and psychosocial processes to influence outcomes
  • mechanisms of treatment and interventions, including how pharmacological, psychological and therapeutic approaches modulate biological and cognitive pathways
  • drivers and trajectories of gambling disorder, including the role of gambling products, advertisement and environments in the course of gambling disorder from progression, maintenance, recovery and relapse
  • stratification and personalised approaches such as identifying sub-groups most likely to benefit from tailored treatments or intervention strategies

These are areas that have been highlighted as current gaps, but this list is not exhaustive. Applicants are encouraged to focus on the most pressing challenges, particularly those that can generate new knowledge and have the potential for real-world impact in preventing, treating or reducing gambling disorder.

Out of scope

The following are not within remit of this funding opportunity:

  • research focusing on broader social or population-level determinants of gambling disorder. While these factors are recognised as important contributors to gambling disorder and related harms, this funding opportunity is specifically focused on experimentally investigating causal biological, cognitive and psychosocial mechanisms in humans
  • proposals which cannot demonstrably evidence that the chosen intervention is experimentally manipulating the target of interest/selectively perturbing the proposed mechanism
  • observational or correlational research that does not determine the mechanism through which an effect is exerted
  • studies relying primarily on patient-reported or quality of life outcomes to assess the effectiveness of the intervention/ challenge, without assessment of the proposed causal mechanism
  • research that does not involve human participants.

Additional funding opportunity requirements

Evidence of meaningful public and patient involvement in applications is essential to ensure that the implications of lived experience as well as the safeguarding and protection of study participants have been considered. Public and patient contributors may be invited to review and assess application lay summaries and provide feedback on the relevance and impact of the proposed research.

Successful projects will be required to work closely with the Gambling Harms Research UK Centre upon award. You should frame your research in terms of how insights can meaningfully advance the field as a whole and in the wider landscape of the gambling levy funding.

As part of our commitment to creating an independent research ecosystem on gambling harms, and to ensure fairness, transparency, and compliance with UKRI policies and standards, the project lead and each project co-lead must complete a Declaration of Interests Form (DoI). See Supporting documents.

For more information on the background of this funding opportunity, go to the Additional information section.

What your application must include

Your application must involve an experimental investigation in humans at its core, which has been designed to validate a mechanistic hypothesis. This should include an intervention or challenge, such as:

  • pharmacological
  • physiological
  • psychological or behavioural (linked to sustained biological read-outs)
  • environmental (social and commercial, such as product design features, that can be causally manipulated)
  • immunological

Broader social determinant-related interventions such as housing quality, literacy and income level are an out-of-scope intervention or challenge for this funding opportunity. The intervention or challenge must experimentally manipulate biological, cognitive or psychosocial causal mechanisms in humans.

Activities we support

The following types of work are eligible for support:

  • the use of novel readouts or technologies related to early evaluation of a pathological mechanism
  • the use of drugs, other interventions or measures, with established safety profiles in new settings or conditions. For example, repurposing drugs as tool compounds to investigate mechanisms
  • the use of gambling product characteristics and gambling environments (for example, gambling adverts or gambling design features to probe mechanism)

We also support work activities that include the characterisation or phenotyping of subjects using samples from clinical studies or at-risk cohorts where there is a clear link to a current experimental medicine strategy. However, this should not be the primary or sole focus of your application.

Limited, hypothesis-driven, retrospective analysis may be included at the start of the project to improve the design of the interventional, experimental medicine study. Milestone criteria should clearly detail what data is required from the confirmatory analysis for the project to progress.

Prospective, nested studies within a larger cohort trial may be eligible provided they:

  • can demonstrate added value
  • are exploring mechanisms of gambling disorder
  • test a novel hypothesis
  • address a different question to the main study

Competitive applications will aim to address a clear mechanistic question and provide strong rationale to justify the suitability of the research and experimental system proposed to test the presented hypothesis.

Activities we do not support

The following activities are not eligible for support through this funding opportunity:

We strongly encourage you to contact us at gamblingexpmed@mrc.ukri.org to discuss your application, especially if you believe your research may cross MRC or research council interests.

Duration

The duration of this award is up to three years.

Projects must start by 1 April 2028 and end by April 2031.

Milestones

Milestones allow us to mitigate risk and support potentially high-risk, innovative projects.

Experimental medicine awards will typically have at least two milestones with defined success criteria that reflect timely progression points and allow mechanistic hypotheses to be laid out and assessed as the project moves forward.

Your milestones should also provide a realistic indication of timelines for key steps, such as regulatory steps, study team recruitment, participant recruitment, study completion and data analysis.

Milestone success criteria should be SMART (specific, measurable, achievable, relevant and timely) and detail any robust ‘go or no-go’ criteria. For all projects, it is advisable to structure the project so that the critical questions are addressed as early as possible in the plan.

Funding available

The FEC of your project can be up to £3 million.

MRC will fund 80% of the FEC.

What we will fund

You can request funding for costs such as:

  • a contribution to the salary of the project lead
  • a contribution to the salary of any co-leads
  • support for other posts such as research and technical staff
  • research consumables
  • equipment
  • travel costs
  • data preservation, data sharing and dissemination costs
  • estates and indirect costs
  • NHS research costs. Following authorisation from the AcoRD specialist, the Schedule of Events Cost Attribution Tool (SoECAT) ‘study information’ and ‘summary’ page of the ‘funder export’ must accompany the invited stage two application
  • public partnerships and related activities, including payments to public contributors

Note: If you are applying as a new investigator, you are able to request up to 50% of your total working time. As a new investigator, the salary should be in line with the host research organisation’s usual new investigator levels. New investigators’ salary costs will be funded at 80% of the FEC for the proportion of the time requested.

You can also request costs for work to be undertaken at international organisations by international project co-leads. We will fund 100% of the eligible costs. The total of such costs requested for international applicants from high-income countries (those not on the Organisation for Economic Cooperation and Development (OECD) Development Assistance Committee (DAC) list of official development assistance recipients), India and China must not exceed 30% of the total resources requested.

There is no cap on costs requested for international applicants from Development Assistance Countries (DAC) list of countries.

For more information on international costs and what we will and will not fund see costs we fund and the Collaborate with Researchers in Norway guidance.

How you spend your time (new investigators only)

New investigator awards are intended to support a research project, combined with a range of other academic or clinical activities, during the transition to independence, such as:

  • time spent on other research grants
  • clinical duties
  • teaching
  • research organisation administration duties
  • other time spent in faculty

To enable new investigator applicants to combine their research project with other activities, applicants are expected to request funding for up to 50% of their contracted working time, as determined by the project. If you want to spend more than 50% of your working time on the project, a strong scientific justification must be provided.

What we will not fund

We will not fund:

  • clinical studies designed to assess the safety or efficacy of treatments
  • costs for PhD studentships
  • publication costs
  • funding to use as a ‘bridge’ between grants

Project partner

A project partner is a collaborating organisation in the UK or overseas, including partners based in the EU, who will have an integral role in the proposed research. You may include project partners that will support your research project through cash or in-kind contributions, such as:

  • staff time
  • access to equipment
  • sites or facilities
  • the provision of data
  • software or materials
  • recruitment of people as research participants
  • providing samples, such as human tissue, for the project

Each project partner must provide a statement of support. If your application involves industry partners, they must provide additional information if the team project partner falls within the industry collaboration framework.

Find out more about subcontractors and dual roles.

Please note the requirement for independence from gambling industry affiliations. Please contact rpginfo@ahrc.ukri.org before applying to discuss conflicts of interest related to this funding opportunity.

Who cannot be included as a project partner

Any individual included in your application with a core team role cannot also be a project partner.

Any organisation that employs a member of the application core team cannot be a project partner organisation. This includes other departments within the same organisation.

If you are collaborating with someone in your organisation, consider including them in the core team as project co-lead, or specialist. They cannot be a project partner.

Supporting skills and talent

We encourage you to follow the principles of the Concordat to Support the Career Development of Researchers and the Technician Commitment.

Trusted Research and Innovation (TR&I)

UK Research and Innovation (UKRI) has a long-standing and continuing commitment to supporting and enabling safe and effective collaboration in research and innovation. UKRI is equally committed to ensuring that this takes place with integrity and within strong ethical frameworks.

Our Principles and expectations set out the principles that UKRI applies to TR&I and our general expectations of the research organisations (including businesses, research institutes, and research technical organisations) that we support. Organisations supported by UKRI should be able to provide evidence that their internal controls and processes meet these expectations.

See further guidance and information about TR&I, including where you can find additional support.

How to apply

We are running this funding opportunity on the new UK Research and Innovation (UKRI) Funding Service so please ensure that your organisation is registered. You cannot apply on the Joint Electronic Submissions (Je-S) system.

The project lead is responsible for completing the application process on the Funding Service, but we expect all team members and project partners to contribute to the application.

Only the lead research organisation can submit an application to UKRI.

To apply

Select ‘Start application’ near the beginning of this Funding finder page:

  1. Confirm you are the project lead.
  2. Sign in or create a Funding Service account. To create an account, select your organisation, verify your email address, and set a password.
  3. Answer questions directly in the text boxes. You can save your answers and come back to complete them or work offline and return to copy and paste your answers. If we need you to upload a document, follow the upload instructions in the Funding Service. All questions and assessment criteria are listed in the How to apply section on this Funding finder page.
  4. Allow enough time to check your application in ‘read-only’ view before sending to your research office.
  5. Send the completed application to your research office for checking. They will return it to you if it needs editing.
  6. Your research office will submit the completed and checked application to UKRI.

Please be aware that research office and finance teams undertake checks on hosting arrangements and financial eligibility. The ultimate responsibility for ensuring compliance with all opportunity requirements lies with the applicant.

Where indicated, you can also demonstrate elements of your responses in visual form if relevant.

When including images, you must:

  • provide a descriptive caption or legend for each image immediately underneath it in the text box (this must be outside the image and counts towards your word limit)
  • insert each new image on a new line
  • use files smaller than 5MB and in JPEG, JPG, JPE, JFI, JIF, JFIF, PNG, GIF, BMP or WEBP format

Images should only be used to convey important visual information that cannot easily be put into words. The following are not permitted, and your application will be rejected if you include:

  • sentences or paragraphs of text
  • tables
  • excessive quantities of images

A few words are permitted where the image would lack clarity without the contextual words, such as a diagram, where text labels are required for an axis or graph column.

For more guidance on the Funding Service, see:

References

References should be included within the word count of the appropriate question section. You should use your discretion when including references and prioritise those most pertinent to the application.

Hyperlinks can be used in reference information. When including references, you should consider how your references will be viewed and used by the assessors, ensuring that:

  • references are easily identifiable by the assessors
  • references are formatted as appropriate to your research
  • persistent identifiers are used where possible

General use of hyperlinks

Applications should be self-contained. You should only use hyperlinks to link directly to reference information. You must not include links to web resources to extend your application. Assessors are not required to access links to conduct assessment or recommend a funding decision.

Generative artificial intelligence (AI)

Use of generative AI tools to prepare funding applications is permitted, however, caution should be applied.

For more information see our policy on the use of generative AI in application and assessment.

Deadline

MRC must receive your application by 14 April 2027 at 4:00pm UK time.

You will not be able to apply after this time.

Make sure you are aware of and follow any internal institutional deadlines.

Following the submission of your application to this funding opportunity, your application cannot be changed, and submitted applications will not be amended. If your application does not follow the guidance, it may be rejected.

Personal data

Processing personal data

MRC, as part of UKRI, will need to collect some personal information to manage your Funding Service account and the registration of your funding applications. We will handle personal data in line with UK data protection legislation and manage it securely. For more information, including how to exercise your rights, read our privacy notice.

MRC, as part of UKRI, may share applications and personal information contained within them with relevant government departments, public bodies, charities or other prospective funding partners where this is necessary for assessment, co-funding, award management or related funding activities. Any such sharing will be undertaken in accordance with UKRI’s privacy notices and applicable data protection legislation. For more information, including how to exercise your rights, read our privacy notice.

MRC, as part of UKRI, will need to share the application and any personal information that it contains with Department for Culture, Media and Sport (DCMS) so that they can participate in the assessment process. For more information on how DCMS uses personal information, visit the DCMS personal information charter.

Sensitive information

If you or a core team member need to tell us something that you wish to remain confidential, email gamblingexpmed@mrc.ukri.org

Include in the subject line: [the funding opportunity title; sensitive information; your Funding Service application number].

Typical examples of confidential information include:

  • individual is unavailable until a certain date (for example due to parental leave)
  • declaration of interest
  • additional information about eligibility to apply that would not be appropriately shared in the ‘Applicant and team capability’ section
  • conflict of interest for UKRI to consider in reviewer or panel participant selection
  • the application is an invited resubmission

For information about how UKRI handles personal data, read UKRI’s privacy notice.

Institutional matched funding

There is no requirement for matched funding from the institutions hosting the project lead, project co-leads or other staff employed on the application, beyond the standard 20% FEC. Expert reviewers and panels assessing UKRI funding applications must not consider levels of institutional matched funding as a factor on which to base recommendations. Direct and in-kind contributions from third party project partners are encouraged.

This policy does not remove the need for support from host organisations who must provide the necessary research environment and infrastructure for award-specific activities funded by UKRI. For example, research facilities, training and development of staff.

Publication of outcomes

MRC, as part of UKRI, will publish the outcomes of this funding opportunity at board and panel outcomes.

If your application is successful, we will publish some personal information on the UKRI Gateway to Research.

Summary

Word limit: 550

In plain English, provide a summary we can use to identify the most suitable experts to assess your application.

We usually make this summary publicly available on external-facing websites, therefore do not include any confidential or sensitive information. Make it suitable for a variety of readers, for example:

  • opinion-formers
  • policymakers
  • the public
  • the wider research community

Guidance for writing a summary

Clearly describe your proposed work in terms of:

  • context
  • the challenge the project addresses
  • aims and objectives
  • potential applications and benefits

Core team

List the key members of your team and assign them roles from the following:

  • project lead (PL)
  • project co-lead (UK) (PcL)
  • project co-lead (international) (PcL (I))
  • specialist
  • grant manager
  • professional enabling staff
  • research and innovation associate
  • technician
  • visiting researcher
  • researcher co-lead (RcL) (Not applicable role for new investigator applications)

Only list one individual as project lead. If you include more than one project lead your application will fail at the checking stage.

UKRI has introduced a new addition to the ‘Specialist’ role type. Public contributors such as people with lived experience can now be added to an application.

For all roles, with the exception of public contributors such as people with lived experience, individuals must be based at the lead organisation or a collaborating organisation. Collaborating organisations are those organisations where project co-leads are based. Team members cannot be based at any other organisation.

Find out more about UKRI’s core team roles in funding applications.

New investigator applications

You should note that the role of researcher co-lead (RcL) is not permitted to be selected when you are applying as a new investigator.

To make your leadership role clear and justify the team around you, we encourage you to use the appropriate application sections such as applicant and team capability to deliver.

Application questions

Keywords

Word limit: 10

Provide up to five keywords that describe your application.

What the assessors are looking for in your response

Provide up to a maximum of five keywords including the health area, for example: mental health, engineering biology, environmental health, diagnosis, obesity, vaccine development.

Use commas or spaces to distinguish individual terms or phrases.

This is for administrative purposes to help with the initial application processing and will not affect the overall assessment or influence the outcome of your application.

Related applications

Word limit: 1,500

Is this application a resubmission of a previous experimental medicine stage one or an invited resubmission of a stage two application? If yes, please outline feedback received and the changes made in response to it.

What the assessors are looking for in your response

If your application is not a resubmission, enter ‘n/a’ in the text box, mark this section as complete, and proceed to the next question.

If your application is an invited resubmission to this funding opportunity, please provide the previous application reference number and details of any invitation from MRC permitting the resubmission.

Ensure that you describe:

  • how this application differs from the previous application
  • how the previous feedback has been considered and addressed

References may be included within this section.

You may demonstrate elements of your responses in visual form if relevant. Further details are provided in the Funding Service.

New investigator applicants

Word limit: 10

Do you consider yourself eligible to apply as a new investigator for this funding opportunity?

What the assessors are looking for in your response

If you are eligible to apply as a new investigator, answer ‘Yes’ in the text box. At stage two, new investigators will be asked to provide information about their eligibility, career development and research organisation support.

If you are not applying as a new investigator, you will be able to indicate this in the Funding Service.

Find out more about eligibility and applying for a New Investigator Award.

Vision

Word limit: 550

What are you hoping to achieve with your proposed work?

What the assessors are looking for in your response

Explain how your proposed work:

  • is of excellent quality and importance within or beyond the field(s) or area(s)
  • has the potential to advance current understanding, or generate new knowledge, thinking or discovery within or beyond the field or area
  • is timely given current trends, context, and needs
  • impacts world-leading research, society, the economy, or the environment
  • aligns with and advances the intentions of the gambling levy

Within the ‘Vision’ section we also expect you to:

  • outline the current clinical challenge, healthcare burden or knowledge gap
  • summarise the current state of understanding about the relevant mechanisms of gambling disorder
  • identify the current gap in mechanistic understanding
  • state the mechanistic hypothesis to be tested
  • identify the potential direct or indirect benefits and who the beneficiaries might be
  • if applicable, describe the route to patient benefit

References may be included within this section.

You may demonstrate elements of your responses in visual form if relevant. Further details are provided in the Funding Service.

Intervention

Word limit: 275

What is the planned intervention?

What the assessors are looking for in your response

Explain the planned intervention to be used in the proposed work, including:

  • the type of intervention, which may include compound, biologic, psychological, physiological, behavioural, immunological or environmental challenge
  • relevant background information, including its established safety or acceptability profile and use in other mechanistic studies

References may be included in this section.

You may demonstrate elements of your responses in visual form if relevant. Further details are provided in the Funding Service.

Approach

Word limit: 2,000

How are you going to deliver your proposed work?

What the assessors are looking for in your response

Provide an outline of your project plan, including key milestones, the proposed methodology and experimental design, an adapted risk management strategy, and access to the infrastructure and equipment required to deliver the project.

We suggest you structure your response using the following headings, with approximate words counts for each:

  • project plan and milestones: 750 words
  • methodology and experimental design: 750 words
  • risk management: 300 words
  • infrastructure and equipment: 200 words

References may be included throughout the ‘Approach’ section. We suggest you include your references under the most relevant heading. Any references you include count towards the approximate word limit indicated for each heading.

Project plan and milestones

Provide an outline project plan, including project milestones and timelines, demonstrating:

  • how you propose to address the identified gap in knowledge
  • the objectives of the proposed research in order of priority
  • the primary and secondary experimental outcomes and how they relate to the experimental objectives
  • how the proposed work packages will ensure the project objectives are achieved
  • the success criteria that will be used for each milestone, detailing the robust ‘go or no-go’ criteria

To support your project plan, you must also provide an embedded legible Gantt chart that should include project tasks and project milestones.

Experimental medicine projects must include at least two progression milestones which are:

  • major specifically-timed decision points (including the project end goal)
  • defined by SMART (specific, measurable, achievable, relevant and timely success criteria and, where appropriate, detailed and robust ‘go or no-go’ criteria
Methodology and experimental design

Outline the proposed methodology and experimental design, including:

  • the experiments you will undertake to probe the stated hypothesis
  • the data you will collect and how it will test the hypothesis
  • the proposed trial design and why this approach is appropriate to meet the study objectives

As part of your methodology and experimental design, outline the nature of human participation in your proposed work, including:

  • the characteristics of the participants (such as age, disease) and the rationale for their selection
  • target and acceptable levels of participant recruitment across the project timeline
  • evidence of recruitment feasibility
  • how you will obtain the necessary ethical and regulatory approvals, including the current status of any approvals. Consider the MRC guidance on ethics and approvals
  • the participant recruitment strategy, including the steps that will be taken if patient recruitment does not reach the set target
  • if applicable, outline how any limited animal, library specimen or isolate cell work will inform the human-centric proposed work. For any research involving animals, tissues and cells, you must show how you will use male and female donors in line with MRC guidance on sex in experimental design. If you are not proposing to do this, a strong justification is required
  • if applicable, explain and justify the inclusion of public partnerships and the added value these offer

You should detail any information regarding your statistical analysis plan in the ‘Reproducibility and statistical design’ section.

Risk management

Outline the project risks and risk management, including:

  • how likely the risks are to occur
  • what their impact would be on the success and deliverability of the project
  • your risk mitigation strategy, giving particular consideration to any potential safety risks and how these risks will be managed, by whom and related escalation or mitigations procedures

You may use a risk table to support your response.

Infrastructure and equipment

You should also demonstrate access to the appropriate services, clinical support, facilities, infrastructure, or equipment to deliver the proposed work, including details of:

  • specialist equipment or infrastructure required to deliver the project objectives
  • the use of existing clinical infrastructure such as NIHR Biomedical Research Centres, NIHR Clinical research facilities, patient cohorts

You may demonstrate elements of your responses in visual form if relevant. Further details are provided in the Funding Service.

Reproducibility and statistical design

Word limit: 250

How will you ensure your proposed work is reliable, robust and reproducible?

What assessors are looking for in your response

Provide a statistical analysis plan.

We expect you to seek professional statistical or other relevant advice in preparing your statistical analysis plan, which may include:

  • sample and effect sizes
  • planned statistical analyses

Ensure you provide sufficient details to justify your proposed samples and effect sizes, and statistical analysis plan, and any assumptions used

Refer to the MRC guidance for applicants for further information, examples and online tools.

You may demonstrate elements of your responses in visual form if relevant. Further details are provided in the Funding Service.

Applicant and team capability to deliver

Word limit: 1,800

Why are you the right individual or team to successfully deliver the proposed work?

What the assessors are looking for in your response

Evidence of how you, and if relevant, your team have:

  • the relevant experience (appropriate to career stage) to deliver the proposed work
  • the right balance of skills and expertise to cover the proposed work
  • the appropriate leadership and management skills to deliver the work and your approach to develop others
  • contributed to developing a positive research environment and wider community

You may demonstrate elements of your responses in visual form if relevant. Further details are provided in the Funding Service.

The word count for this section is 1,800 words:

  • 1,100 words to be used for Résumé for Research and Innovation (R4RI) modules (including references)
  • 200 words to summarise the career stage of the core team (an example table will be provided within the Funding Service to assist you with your summary)
  • 500 words for Additions, if necessary

Use the R4RI format to showcase the range of relevant skills you and, if relevant, your team (project lead and project co-leads, researchers, technicians, specialists, partners and so on) have and how this will help deliver the proposed work. You can include individuals’ specific achievements but only choose past contributions that best evidence their ability to deliver this work. You are encouraged to include ORCID iDs for individuals where relevant, as this can help to demonstrate and verify their achievements.

Complete this section using the R4RI module headings listed. Use each heading once and include a response for the whole team, see the UKRI guidance on R4RI. You should consider how to balance your answer, and emphasise where appropriate the key skills each team member brings:

  • contributions to the generation of new ideas, tools, methodologies, or knowledge. This may include your previous funding and key outputs such as publications
  • the development of others and maintenance of effective working relationships
  • contributions to the wider research and innovation community
  • contributions to broader research or innovation users and audiences and towards wider societal benefit, including public partnerships
  • if you are applying as a new investigator, you need to make your leadership role clear and justify the team around you
Additions

Provide any further details relevant to your application. This section is optional and can be up to 500 words. You should not use it to describe additional skills, experiences, or outputs, but you can use it to describe any factors that provide context for the rest of your R4RI (for example, details of career breaks if you wish to disclose them).

Complete this as a narrative. Do not format it like a CV.

References may be included within this section.

Project partners

Add details about any project partners contributions. If there are no project partners, you can indicate this on the Funding Service.

A project partner is a collaborating person or organisation who will have an integral role in your proposed research. This may include direct contributions for example cash, donated equipment and resources, or staff seconded to the project, or indirect and in-kind contributions for example use of project partner’s equipment, datasets, or facilities. Project partners may be in industry, academia, third sector or government organisations in the UK or overseas, including partners based in the EU.

A project partner is not anyone in your core team or anyone from your organisation or any of the other organisations represented by core team members.

If an individual or organisation outside the core team is responsible for recruiting people as research participants or providing human tissue for this project, list them as a project partner.

Add the following project partner details:

  • the organisation name (searchable via a drop-down list or enter the organisation’s details manually, as applicable)
  • the project partner contact name and email address
  • the type of contribution (direct or in-direct) and its monetary value

If a detail is entered incorrectly and you have saved the entry, remove the specific project partner record and re-add it with the correct information.

If there are specific circumstances where project partners do require funding for minor costs such as travel and subsistence, these project partner costs should be claimed and justified in the ‘Resources and costs’ section when submitting an invited stage two application. (Note: the ‘Resources and costs’ section is only applicable during the invited stage 2 application process).

Please note the requirement for independence from gambling industry affiliations. Please contact rpginfo@ahrc.ukri.org before applying to discuss conflicts of interest related to this opportunity.

Important information

If you are adding a project partner to this section, you must ensure they provide you with a letter or email of support and you upload it to ‘Project partners: letters or emails of support’.

If your project partners are from industry or a company, you must also complete the ‘Industry Collaboration Framework (ICF)’ section (Note: the ICF section is only applicable during the invited stage two application process).

Project partners responsible for carrying out animal work

If the project partner is responsible for conducting animal work or providing animals or animal tissue samples, you must ensure that you complete and upload the appropriate forms under the ‘Animal Involvement and ‘3Rs’ section (if applicable). Note: the ‘Research involving the use of animals’ and ‘Conducting research with animals overseas’ are only applicable during the invited stage two application process.

For audit purposes, UKRI requires formal collaboration agreements to be put in place if an award is made.

Project partners: letters (or emails) of support

Word limit: 10

Upload a single PDF containing the letters or emails of support from each partner you named in the ‘Project partners’ section. These should be uploaded in English or Welsh only.

What the assessors are looking for in your response

If you do not have any project partners, you will be able to indicate this in the Funding Service.

What supporting statements we are looking for

We are looking for you to provide letters or emails of support from all your identified project partners.

What we are not looking for

We do not want any other letters (or emails) of support, from people who are not your identified project partners, such as those simply expressing general support for your project. If these are included by you, they will be ignored by us and will not be used in the assessment process.

Important information

You should only provide letters or emails of support from people you have identified in the project partner section of your application, who will have an integral role in your proposed research.

What each project partner letter or email of support must include

Each project partner letter or email you provide should:

  • include the name of the project partner organisation and contact information
  • explain the project partners’ commitment to the project
  • explain the value, relevance, and possible benefits of the proposed work, to them
  • describe any additional value they will bring to the project
  • not exceed two sides of A4 per project partner

Project partner letters and emails of support are not required to be on headed paper or include handwritten signatures (electronic signatures are acceptable).

The Funding Service will provide document upload details when you apply.

Project partners from industry or a company

Industry or company project partners are required to download and complete the industry or company letter of support template. Note: this is applicable to invited stage two submissions only.

Project partners responsible for recruiting research participants or providing human tissue or samples

If the project partner is responsible for the recruitment of people as research participants or providing human tissue their letter or email of support should include:

  • agreement that the project partner will recruit the participants or provide tissue
  • confirmation that what is being supplied is suitable for the proposed work
  • confirmation that the quantity of tissue being supplied is suitable, but not excessive for achieving meaningful results (if applicable)
Agreement with your project partners

Ensure you have prior agreement from project partners so that, if you are offered funding, they will support your project as indicated in the ‘Project partners’ section.

For audit purposes, UKRI requires formal collaboration agreements to be put in place if an award is made.

Outline costs

What are the expected costs of the proposed work?

Provide the approximate total values in GBP (£) for the expected directly incurred, directly allocated, indirect costs and exceptions. View the guidance on the costs you can apply for.

Ethics and responsible research and innovation (RRI)

What are the ethical and RRI considerations, implications and issues relating to the proposed work? If you do not think that the proposed work raises any ethical or RRI issues, explain why.

What the assessors are looking for in your response

Demonstrate that you have identified and evaluated:

  • the relevant ethical and RRI considerations, including both the research or topic area itself and the design and delivery of the project
  • the wider implications of the proposed work, and how you will maximise the positive societal, environmental, and economic benefits arising from the project, while minimising unintended negative impacts, such as research misuse or accidental harm
  • how you will manage these considerations throughout the lifecycle of the project

Please refer to the UKRI position statement on funding ethical research and Responsible innovation for more information around our expectations on ethical and responsible research and innovation.

Declaration of Interests Form (DoI)

Word limit: 10

As part of our commitment to creating an independent research ecosystem on gambling harms, and to ensure fairness, transparency, and compliance with UKRI policies and standards, the project lead and each project co-lead must complete a DoI.

Please contact rpginfo@ahrc.ukri.org to discuss conflicts of interest to this opportunity.

What the assessors are looking for in your response

Please download the Declaration of Interest Form (DOCX, 43KB) and follow the guidance below:

Comprehensive disclosure

List all relevant interests, including:

  • current and past funding from gambling operators, industry-linked charities, or advocacy groups
  • consultancy, advisory, or employment roles with gambling-related organisations
  • indirect links (for example, student projects, collaborations, or programme-level funding)
  • other industry ties that may raise concerns (for example, technology or pharma)

Do not omit details mentioned elsewhere in your application or in public registers of interest.

Transparency and trust

The purpose of the DoI is not to exclude applicants but to ensure trust and transparency. A well-detailed declaration with thoughtful mitigations strengthens your application and aligns with UKRI’s expectations. If there is something you are unsure about, include it. It is better to overshare than omit potentially important information.

Mitigations

Provide clear, specific mitigations for both current and future conflicts.

Examples include:

  • ceasing previous projects by a set date
  • programme-level separation when institutional funding overlaps
  • using transparency measures when lived experience groups have industry ties
  • avoiding vague statements (for example, ‘we will follow guidance’) unless referencing verified, existing frameworks
  • including details on how evidence bases and existing data sources will be used and scrutinised
Future planning

Outline how you will manage potential conflicts going forward, such as:

  • plans to avoid industry funding
  • safeguards for stakeholder engagement (for example, not working with licence holders)
  • independent oversight mechanisms
Consistency across documents

Ensure your DoI form is consistent with your application and other public registers of interest. Any omission of declared collaborations or funding will be treated seriously and may result in funding being revoked.

Clarity and detail

Provide enough detail for reviewers to understand, including:

  • the nature of the relationship (for example, employment, funding, or consultancy)
  • the timeline (past, current and future)
  • the scope (direct or indirect funding)

Avoid minimalist or identical declarations without explanation.

Lived experience organisations

If involving lived experience groups:

  • declare their funding sources
  • provide mitigations to address perceptions of conflict if they have industry ties

The Funding Service will provide document upload details when you apply.

Trusted Research and Innovation (TR&I)

Trusted Research and Innovation is the protection of the UK’s intellectual property, sensitive research, people, and infrastructure from potential theft, misuse, and exploitation.

Organisations receiving UKRI funding are obliged to act in line with UK government legislation. They are also expected to undertake appropriate due diligence assessments of organisations involved in research partnerships, collaboration agreements, and commercial contracts.

You will be asked about:

  • which areas of the National Security and Investment (NSI) Act your project relates to
  • who you intend to collaborate with and how
  • if your project requires an export control licence

Your answers may affect the T&Cs of your funding agreement if you are successful. We may use your answers to determine that our current T&Cs are sufficient or if additional T&Cs are required.

How we will assess your application

Assessment process

We will assess your application using the following process.

Your application will be assessed in a two-stage process.

Panel

Your stage one application will be considered by an independent panel of experts.

If successful, you will be invited to submit a stage two application, which will undergo further assessment.

The decisions of the Experimental Medicine Panel are not open to appeal.

For more information on how we prioritise applications for funding please visit How we make decisions.

Timescale

We aim to complete the process from stage one submission to stage two funding decision in approximately 35 weeks.

If you are successful at stage one, you will be invited to submit to the next stage two round planned to open 15 April 2027 with a closing date of 1 September 2027.

Feedback

We will notify you of the outcome of your stage one application within 10 working days of the stage one panel meeting. We will give feedback within eight weeks of the stage one panel meeting.

Principles of assessment

We support the San Francisco declaration on research assessment and recognise the relationship between research assessment and research integrity.

Find out about the UKRI principles of assessment and decision making.

Using generative artificial intelligence (AI) in expert review

Generative AI may only be used for the purpose of language refinement during application assessment. When using generative AI to refine the language of a review, expert reviewers and panellists must ensure that:

  • no part of the application being assessed is entered into a generative AI tool
  • no personal information from the application is disclosed
  • generative AI is not tasked with understanding, summarising or evaluating the application’s content

Expert reviewers and panellists must also:

  • comply with relevant intellectual property and data protection legislation
  • not take into account or speculate within their assessment whether generative AI has been used to develop the application

For more detail see our policy on the use of generative AI.

Sharing data with co-funders

We will need to share the application (including any personal information that it contains) with Department for Culture, Media and Sports (DCMS) so that they can participate in the assessment process.

For more information on how DCMS uses personal information, visit the DCMS personal information charter for further detail.

We reserve the right to modify the assessment process as needed.

Assessment areas

The assessment areas we will use are:

  • fit to the funding opportunity scope
  • vision of the project
  • capability of the applicants and team to deliver the project
  • ethical and responsible research and innovation considerations of the project
  • resources requested to do the project

We will also assess your approach to your proposed work, including:

  • project plan and milestones
  • methodology, experimental and statistical design
  • risk management and mitigation planning
  • research environment and infrastructure

Find details of assessment questions and criteria under the ‘Application questions’ heading in the ‘How to apply’ section.

Contact details

Get help with your application

If you have a question and the answers aren’t provided on this page

The helpdesk is committed to helping users of the UK Research and Innovation (UKRI) Funding Service as effectively and as quickly as possible. In order to manage cases at peak volume times, the helpdesk will triage and prioritise those queries with an imminent opportunity deadline or a technical issue. Enquiries raised where information is available on the Funding finder opportunity page and should be understood early in the application process (for example, regarding eligibility, content or remit of a funding opportunity) will not constitute a priority case and will be addressed as soon as possible.

Contact details

For help and advice on costings and writing your application please contact your research office in the first instance, allowing sufficient time for your organisation’s submission process.

For questions related to this specific funding opportunity please contact gamblingexpmed@mrc.ukri.org

For questions related to including project partners and declaring conflicts of interest, please contact rpginfo@ahrc.ukri.org

For general questions related to MRC funding including our funding opportunities and policy please contact rfpd@mrc.ukri.org

Any queries regarding the system or the submission of applications through the Funding Service should be directed to the helpdesk.

Email: support@funding-service.ukri.org

Phone: 01793 547490

Our phone lines are open:

  • Monday to Thursday 8:30am to 5:00pm
  • Friday 8:30am to 4:30pm

To help us process queries more efficiently, we request that users highlight the council and opportunity name in the subject title of their email query, include the application reference number, and refrain from contacting more than one mailbox at a time.

For further information on submitting an application read How applicants use the Funding Service.

Additional info

Background

In April 2023, the Department for Culture, Media, and Sports (DCMS) published a white paper setting out the government’s plans for modernising regulation of the gambling sector. One of the key proposals in the white paper is the introduction of a statutory levy on gambling operators.

Following a public consultation, which ran from 17 October 2023 to 14 December 2023, and an analysis of the responses to the consultation, the government has introduced a statutory levy charged to all licenced gambling activity. This is at varying levels depending on the sector and nature of the gambling activity to ensure impacts are proportionate.

The statutory levy was introduced via secondary legislation and commenced in April 2025 with funding flowing later that year. The levy will be collected and administered by the Gambling Commission under the strategic direction of the government, replacing the current system of voluntary industry contributions.

Levy funding will be directed in specific proportions for the purposes of research, prevention, and treatment. Each stream of the levy system will also have a central commissioner. The streams are:

  • research (20% of funding to UKRI and the Gambling Commission for the establishment of a bespoke research programme)
  • prevention (30% of funding to the Office for Health Improvement and Disparities (OHID) to create a co-ordinated GB-wide approach to prevention)
  • treatment (50% of funding to the NHS in England, Scotland, and Wales to commission treatment and support services)

Within the stream of funding allocated to UKRI for the new Research Programme on Gambling (RPG), UKRI have commissioned a multi-disciplinary Gambling Harms Research UK (GHR-UK) Evidence Centre.

This will coordinate a cohort of GHR-UK Innovation Partnerships that have been funded to fill gaps in the existing evidence base and assist UKRI in developing a research agenda following the introduction of the levy.

Further information on the gambling levy can be found in the following resources:

Research and innovation impact

Impact can be defined as the long-term intended or unintended effect research and innovation has on society, economy and the environment; to individuals, organisations, and the wider global population.

Supporting documents

Declaration of Interest Form (DOCX, 43KB)

Equality Impact Assessment for the opportunity (PDF, 339KB)

Webinar for potential applicants

We held a webinar on 5 October 2026. This provided more information about the funding opportunity and a chance to ask questions.

Watch the webinar (YouTube).

Global Talent visa

Researchers are eligible for a Global Talent visa under the ‘exceptional promise’ category for future research leaders.

Updates

  • 22 October 2026
    Added the webinar recording link under 'Webinar for potential applicants' in the additional info section.

This is the website for UKRI: our seven research councils, Research England and Innovate UK. Let us know if you have feedback or would like to help improve our online products and services.